Healthcare Brew · 14 August 2023 · by Maia Anderson
Healthcare Brew asked why venture investors keep backing value-based care companies when the US health system is unlikely ever to move fully away from fee-for-service. Krish Ramadurai, then a Partner at Harmonix, said the first thing he looks for is evidence that a company has produced a tangible clinical or economic outcome.
“They understand how to derive that better, faster, cheaper outcome.”
Krish Ramadurai, quoted in Healthcare Brew